The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Pinterest (NYSE: PINS) is still trading up from one year ago by close to 16%, although shares are in the red from the start of 2024. The photo sharing and discovery platform has dealt with fluctuating ...

Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Keith Speights has positions in Pfizer and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Merck, Pfizer, and Vertex Pharmaceuticals. The Motley Fool recommends Moderna. The ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...

Vertex Energy Inc (VTNR) stock saw a modest uptick, ending the day at $0.4 which represents a slight increase of $0.05 or 14.29% from the prior close of $0.35. The stock opened at $0.35 and touched a ...

Don't overlook Google Cloud's growth potential. Understand key opportunities and AI growth story to capitalize on future ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Gold climbs to record high US$2568/oz as WA’s Paterson Province and NSW’s Lachlan Fold Belt continue to be hives of activity ...